By Sahil Pandey July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal ...

TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau ...

Life sciences equipment and consumable manufacturer Repligen has reached a deal to buy cell therapy specialist BioLife ...

Repligen Corporation has finalized a definitive agreement to acquire BioLife Solutions, aiming to significantly expand its ...

Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of BioLife Solutions, Inc. (NasdaqCM: BLFS) to Repligen Corporation (NasdaqGS: RGEN). Under the ...

Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s ...

For decades, people seeking regenerative therapies, hormone treatments, or advanced wellness solutions have had to navigate a fragmented system. One physician might offer hormone replacement, another ...

Plasma donation and testing company BioLife Plasma Services LP in has invested $4 million to expand its testing laboratory in Hoover, Ala., and buy equipment to recycle biohazardous plastics waste ...

TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma ...

Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about US$1.5 billion, to ...